Page 98 - rcv31n3.vp

El año 2015 en cardiología: imagenología Revista Uruguaya de Cardiología
Oliver Gaemperli, Victoria Delgado, Gilbert Habib y colaboradores Volumen 31 | nº 3 | Diciembre 2016

fore non-cardiac surgery: prospective cohort study. T2-weighted cardiovascular magnetic resonance.
BMJ 2015;350:h1907. CircCardiovasc Imaging 2014;7:872–9.
14. Burris AC, Boura JA, Raff GL, Chinnaiyan KM. 23. Edwards NC, Moody WE, Yuan M, Weale P,
Triple rule out versus coronary CT angiography in Neal D, Townend JN, Steeds RP. Quantification
patients with acute chest pain: results from the ACIC of left ventricular interstitial fibrosis in asymptoma-
Consortium. JACC Cardiovasc Imaging 2015;8: tic chronic primary degenerative mitral regurgita-
817–25. tion. Circ Cardiovasc Imaging 2014;7:946–53.
15. Douglas PS, Hoffmann U, Patel MR, Mark DB, 24. Ellims AH, Iles LM, Ling LH, Chong B, Mac-
Al-Khalidi HR, Cavanaugh B, et al; PROMISE ciocca I, Slavin GS, et al. A comprehensive evalua-
Investigators. Outcomes of anatomical versus tion of myocardial fibrosis in hypertrophic cardiom-
functional testing for coronary artery disease. N yopathy with cardiac magnetic resonance imaging:
Engl J Med 2015;372:1291–300. linking genotype with fibrotic phenotype. Eur Heart
J Cardiovasc Imaging 2014;15:1108–16.
16. SCOT-HEART investigators. CT coronary angio-
25. Nadel J, Lancefield T, Voskoboinik A, Taylor
graphy in patients with suspected angina due to coro-
AJ. Late gadolinium enhancement identified with
nary heart disease (SCOT-HEART): an open-label,
cardiac magnetic resonance imaging in sarcoidosis
parallel-group, multicentre trial. Lancet 2015;385:
patients is associated with long-term ventricular
2383–91.
arrhythmia and sudden cardiac death. Eur Heart J
17. Douglas PS, Pontone G, Hlatky MA, Patel MR, Cardiovasc Imaging 2015;16:634–641.
Norgaard BL, Byrne RA, et al; PLATFORM
26. Banypersad SM, Fontana M, Maestrini V, Sado
Investigators. Clinical outcomes of fractional flow
DM, Captur G, Petrie A, et al. T1 mapping and
reserve by computed tomographic angiography-gui-
survival in systemic light-chain amyloidosis. Eur
ded diagnostic strategies vs. usual care in patients
Heart J 2015;36:244–51.
with suspected coronary artery disease: the prospec-
tive longitudinal trial of FFRct: outcome and resour- 27. van der ValkFM, Kroon J, Potters WV, Thur-
ce impacts study. Eur Heart J 2015; 36:3359–67. lings RM, Bennink RJ, Verberne HJ, et al. In
vivo imaging of enhanced leukocyte accumulation in
18. Hlatky MA, De Bruyne B, Pontone G, Patel MR, atherosclerotic lesions in humans. J Am Coll Cardiol
Norgaard BL, Byrne RA, et al; PLATFORM 2014;64:1019–29.
Investigators. Qualityoflife and economic outco-
28. van Wijk DF, Sjouke B, Figueroa A, Emami H,
mes of assessing fractional flow reserve with compu-
van der Valk FM, MacNabb MH, et al. Nonphar-
ted tomography angiography: the PLATFORM
macological lipoprotein apheresis reduces arterial
study. J Am Coll Cardiol 2015;66:2315–23.
inflammation in familial hypercholesterolemia. J Am
19. Hoshi T, Sato A, Akiyama D, Hiraya D, Sakai S, Coll Cardiol 2014;64:1418–26.
Shindo M, et al. Coronary high-intensity plaque on
29. Moon SH, Cho YS, Noh TS, Choi JY, Kim BT,
T1-weighted magnetic resonance imaging and its as-
Lee KH. Carotid FDG uptake improves prediction of
sociation with myocardial injury after percutaneous
future cardiovascular events in asymptomatic indivi-
coronary intervention. Eur Heart J 2015;36:
duals. JACC Cardiovasc Imaging 2015;8:949–56.
1913–22.
30. Task Force Members, Montalescot G, Sechtem
20. Schindler TH, Bax JJ. Assessment of coronary ar-
U, Achenbach S, Andreotti F, Arden C, Budaj
tery plaque with non-contrast and T1-weighted mag-
A, et al; ESC Committee for Practice Guideli-
netic resonance: promise for clinical use? Eur Heart J
nes, Zamorano JL, Achenbach S, Baumgartner
2015. Epub ahead of print.
H, Bax JJ, Bueno H, Dean V, et al. 2013 ESC gui-
21. Carrick D, Haig C, Rauhalammi S, Ahmed N, delines on the management of stable coronary artery
Mordi I, McEntegart M, et al. Prognostic signifi- disease: the Task Force on the management of stable
cance of infarct core pathology revealed by quantita- coronary artery disease of the European Society of
tive non-contrast in comparison with contrast car- Cardiology. Eur Heart J 2013;34:2949–3003.
diac magnetic resonance imaging in reperfused 31. Cremer PC, Khalaf S, Agarwal S, Mayer-Sabik
ST-elevation myocardial infarction survivors. Eur E, Ellis SG, Menon V, et al. Myocardial perfusion
Heart J 2015; doi:10.1093/eurheartj/ehv372. Publis- imaging in emergency department patients with ne-
hed online ahead of print 10 August 2015. gative cardiac biomarkers: yield for detecting ische-
mia, short-term events, and impact of downstream
22. Jordan JH, D’Agostino RB Jr, Hamilton CA,
revascularization on mortality. Circ Cardiovasc Ima-
Vasu S, Hall ME, Kitzman DW, et al. Longitudi-
ging 2014;7:912–9.
nal assessment of concurrent changes in left ventri-
cular ejection fraction and left ventricular myocar- 32. Wollenweber T, Roentgen P, Schäfer A, Schat-
dial tissue characteristics after administration of ka I, Zwadlo C, Brunkhorst T, et al. Characteri-
cardiotoxic chemotherapies using T1-weighted and zing the inflammatory tissue response to acute myo-
450